NEW YORK STATE COMMON RETIREMENT FUND - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 263 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2020. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$522
-54.3%
153,524
-1.3%
0.00%0.0%
Q2 2023$1,143
-39.7%
155,542
-14.9%
0.00%
-66.7%
Q1 2023$1,894
-24.8%
182,772
-14.3%
0.00%0.0%
Q4 2022$2,518
-99.9%
213,237
+14.2%
0.00%
-50.0%
Q3 2022$3,918,000
-74.1%
186,676
-61.8%
0.01%
-70.0%
Q2 2022$15,151,000
-28.0%
488,124
-4.7%
0.02%
-9.1%
Q1 2022$21,037,000
-3.3%
512,344
+2.3%
0.02%0.0%
Q4 2021$21,763,000
-21.6%
500,634
-9.7%
0.02%
-26.7%
Q3 2021$27,745,000
-13.4%
554,121
+9.0%
0.03%
-9.1%
Q2 2021$32,026,000
-7.9%
508,429
+35.9%
0.03%
-13.2%
Q1 2021$34,755,000
+6.0%
374,075
+2.3%
0.04%
+2.7%
Q4 2020$32,775,000
-7.0%
365,796
+7.3%
0.04%
-14.0%
Q3 2020$35,242,000
+31.5%
341,061
+0.6%
0.04%
+26.5%
Q2 2020$26,809,000
-23.1%
339,015
-43.7%
0.03%
-34.6%
Q1 2020$34,842,000
+46.7%
602,181
+36.8%
0.05%
+85.7%
Q4 2019$23,756,000
+17.5%
440,338
+13.9%
0.03%
+7.7%
Q3 2019$20,216,000
+5.3%
386,683
-2.7%
0.03%
+8.3%
Q2 2019$19,205,000
+232.4%
397,534
+247.6%
0.02%
+242.9%
Q1 2019$5,778,000
+26.9%
114,369
+48.9%
0.01%0.0%
Q4 2018$4,554,000
-18.0%
76,818
-8.9%
0.01%0.0%
Q3 2018$5,551,000
+19.5%
84,318
-8.4%
0.01%
+16.7%
Q2 2018$4,645,000
+14.7%
92,004
+19.7%
0.01%
+20.0%
Q1 2018$4,048,000
+51.5%
76,881
+33.7%
0.01%
+66.7%
Q4 2017$2,672,000
+8.0%
57,510
-6.0%
0.00%0.0%
Q3 2017$2,474,000
-26.1%
61,166
-38.1%
0.00%
-25.0%
Q2 2017$3,349,000
+33.5%
98,770
+14.3%
0.00%
+33.3%
Q1 2017$2,509,000
-40.8%
86,390
-33.1%
0.00%
-50.0%
Q4 2016$4,238,000
+22.5%
129,042
+17.6%
0.01%
+20.0%
Q3 2016$3,459,000
+66.2%
109,712
+48.2%
0.01%
+66.7%
Q2 2016$2,081,000
-11.8%
74,005
+14.0%
0.00%
-25.0%
Q1 2016$2,360,000
-7.1%
64,916
+2.2%
0.00%0.0%
Q4 2015$2,541,000
+27.6%
63,516
-9.2%
0.00%
+33.3%
Q3 2015$1,992,000
-56.7%
69,916
-50.0%
0.00%
-57.1%
Q2 2015$4,603,000
+108.1%
139,706
+81.7%
0.01%
+133.3%
Q1 2015$2,212,000
+33.6%
76,907
+26.5%
0.00%
+50.0%
Q4 2014$1,656,000
+27.8%
60,8000.0%0.00%0.0%
Q3 2014$1,296,000
-17.0%
60,800
-12.5%
0.00%0.0%
Q2 2014$1,561,000
-9.8%
69,500
+1.5%
0.00%
-33.3%
Q1 2014$1,731,000
+9.9%
68,5000.0%0.00%
+50.0%
Q4 2013$1,575,000
+39.1%
68,500
+15.3%
0.00%0.0%
Q3 2013$1,132,000
+32.1%
59,4000.0%0.00%0.0%
Q2 2013$857,00059,4000.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Zebra Capital Management LLC 20,591$895,0001.43%
Global Alpha Capital Management Ltd. 330,270$14,357,0001.39%
AIMZ Investment Advisors, LLC 73,875$3,211,0001.25%
Hillcrest Asset Management LLC 184,010$7,999,0001.22%
Bridge City Capital, LLC 56,869$2,472,0001.02%
SNYDER CAPITAL MANAGEMENT L P 683,700$29,720,0000.72%
EARNEST PARTNERS LLC 2,188,606$95,139,0000.55%
RICE HALL JAMES & ASSOCIATES, LLC 343,347$14,925,0000.53%
PALISADE CAPITAL MANAGEMENT, LP 584,957$25,428,0000.52%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 45,693$1,986,0000.45%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders